Skip to main content
. 2016 Mar 24;2016(3):CD008286. doi: 10.1002/14651858.CD008286.pub3

Tonnesen 2006.

Methods Setting: 7 chest clinics, Denmark
 Recruitment: outpatient attender motivated to enrol in trial of cessation medication
Participants 370 smokers of >1 cpd with COPD (178 in arms of interest); 52% F, av. age 61, av. cpd 20
 Providers: 20 nurses with cessation experience, trained to support medication use and provide standardised counselling
Interventions Factorial trial. Nicotine sublingual tablet versus placebo and high versus low support
 1. High support: 7 x 20‐30min clinic visits (0, 2, 4, 8, 12 wks, 6m, 12m) & 5 x 10min phone calls (1, 6, 10 wks, 4½m, 9m), total contact time 4½ hrs.
 2. Low support: 4 clinic visits (0, 2 wks, 6m, 12m) & 6 phone calls (1, 4, 6, 9, 12 wks, 9m), total time 2½ hrs
Outcomes Sustained abstinence at 12m (validated at all visits from wk 2, PP also reported)
 Validation: CO < 10 ppm
Notes NRT and high support versus placebo and low support used for meta‐analysis.Therapists were not full time specialist counsellors.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Block randomization list at each centre
Allocation concealment (selection bias) Unclear risk Allocation process not described
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 82 (22%) of total in trial lost to follow‐up, 14 deaths, all included as smokers (support condition not specified for dropouts or deaths)